comparemela.com

Latest Breaking News On - Oncology program at case comprehensive cancer center - Page 1 : comparemela.com

AML, ALL, and Glioblastoma Multiforme Clinical Trials Seek to Push the Needle Forward

Leland Metheny, MD, discusses how agents such as Iomab-B have potential to shift practice in the hematologic malignancy space.

United statesLeland methenyOncology program at case comprehensive cancer centerUniversity hospitals cleveland medical centerCase western reserve university school of medicineCase western reserve university schoolImmune oncology programCase comprehensive cancer centerHematologic oncologyGlioblastoma multiforme

Risk Factors Could Inform BTK Inhibitor and Venetoclax Sequencing in CLL/SLL

Changchun Deng, MD, PhD, discusses factors to consider when sequencing covalent BTK inhibitors and venetoclax in patients with CLL/SLL.

United statesOncology program at case comprehensive cancer centerUniversity hospitals seidman cancer centerChangchun dengImmune oncology programCase comprehensive cancer centerCovalent btk inhibitorsChronic lymphocytic leukemia cllSmall lymphocytic lymphoma

Homing in on Currently Recruiting Clinical Trials With Practice Changing Implications in Lymphoma and Myeloma

Leland Metheny, MD, discusses ongoing clinical trials and their implications for the field of hematologic oncology.

United statesWesley centerCase western reserve universityLeland methenyUniversity hospitals cleveland medical centerCase western reserve university school of medicineOncology program at case comprehensive cancer centerSeidman cancer centerUh wesley centerUniversity hospitals seidman cancer centerScience summitCase western reserve university schoolImmune oncology programCase comprehensive cancer centerSeidman cancerHematologic oncology

Increased Understanding of CLL Tumor Biology Unlocks Targeted CAR T-Cell Approaches

Jan Joseph Melenhorst, PhD, emphasizes how research investigating chronic lymphocytic leukemia biology may result in more targeted CAR T-cell products.

United statesJan joseph melenhorstAdrian wiestnerJamesn kochenderferMichel sadelainLyell immunopharmaNational cancer instituteInternational workshopOncology program at case comprehensive cancer centerUniversity of pennsylvaniaHospital of the university pennsylvaniaCell therapyPrecision immuno oncologyCleveland clinicImmune oncology programCase comprehensive cancer center

vimarsana © 2020. All Rights Reserved.